Epigenetic therapy targeting histone deacetylase in chronic pain

被引：0
|
作者：
Uchida, Hitoshi [1 ]
Araki, Kohei [1 ]
Ueda, Hiroshi [1 ]
机构：
[1] Nagasaki Univ, Grad Sch Biomed Sci, Div Mol Pharmacol & Neurosci, Nagasaki 8528521, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2011年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：101P / 101P
页数：1
相关论文
共 50 条
  • [21] Histone deacetylase inhibitors: highlight on epigenetic regulation
    Pecuchet, N.
    Cluzeau, T.
    Thibault, C.
    Mounier, N.
    Vignot, S.
    BULLETIN DU CANCER, 2010, 97 (08) : 917 - 935
  • [22] Targeting histone deacetylase in thyroid cancer
    Russo, Diego
    Durante, Cosimo
    Bulotta, Stefania
    Puppin, Cinzia
    Puxeddu, Efisio
    Filetti, Sebastiano
    Damante, Giuseppe
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (02) : 179 - 193
  • [23] Targeting histone deacetylase in cardiac diseases
    Lu, Jiao
    Qian, Sichong
    Sun, Zheng
    FRONTIERS IN PHYSIOLOGY, 2024, 15
  • [24] Targeting histone deacetylase in cancer.
    Harrington, EA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2794S - 2794S
  • [25] Epigenetic Modulation of mGlu2 Receptors by Histone Deacetylase Inhibitors in the Treatment of Inflammatory Pain
    Chiechio, S.
    Zammataro, M.
    Morales, M. E.
    Busceti, C. L.
    Drago, F.
    Gereau, R. W., IV
    Copani, A.
    Nicoletti, F.
    MOLECULAR PHARMACOLOGY, 2009, 75 (05) : 1014 - 1020
  • [26] Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: From epigenetic to selective drugs
    Zhang, Wencui
    Jiao, Bo
    Yu, Shangchen
    Zhang, Caixia
    Zhang, Kaiwen
    Liu, Baowen
    Zhang, Xianwei
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (05)
  • [27] A mechanistic approach to anticancer therapy: Targeting the cell cycle with histone deacetylase inhibitors
    Mork, CN
    Faller, DV
    Spanjaard, RA
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1091 - 1104
  • [28] Targeting of endocrine therapy resistance through combined mTOR and histone deacetylase inhibition
    Ordentlich, P.
    Flechsig, S.
    Hoffmann, J.
    CANCER RESEARCH, 2012, 72
  • [29] Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas
    Wagner, Vivian P.
    Martins, Manoela D.
    Martins, Marco A. T.
    Almeida, Luciana O.
    Warner, Kristy A.
    Nor, Jacques E.
    Squarize, Cristiane H.
    Castilho, Rogerio M.
    SCIENTIFIC REPORTS, 2018, 8
  • [30] Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas
    Vivian P. Wagner
    Manoela D. Martins
    Marco A. T. Martins
    Luciana O. Almeida
    Kristy A. Warner
    Jacques E. Nör
    Cristiane H. Squarize
    Rogerio M. Castilho
    Scientific Reports, 8
12345